WORLDSymposium 2022 Emerging Trends
For the tenth consecutive year, WORLDSymposium began with Emerging Trends in Lysosomal Biology & Lysosomal Diseases: State-of-the-art for Experts on Monday, January 31, 2022. More details.
WORLDSymposium 2022 Robert J. Gorlin Symposium
The inaugural Robert J. Gorlin Symposium discussed the urgent need to develop and implement precise metrics for measuring cognitive change in children with lysosomal diseases. Precision Metrics for Cognition brought together leading experts to provide an explanation and rationale for using growth scale values (GSVs) to measure developmental longitudinal cognitive change in children with early onset and severe lysosomal diseases. More details.
WORLDSymposium 2022 Program
After the presentation of the Innovation Award, the formal scientific sessions of WORLDSymposium 2022 officially began with presentations on laboratory research for lysosomal disease. Presentations during the Basic Science sessions are designed to improve our understanding or prediction of the phenomena involved in lysosomal pathology at a molecular, cellular, and animal model level in order to forwardly think about diagnosis and treatment of lysosomal conditions. View full program.
WORLDSymposium 2022 Exhibitors
WORLDSymposium 2022 attracted over 35 Exhibitors and 9 Patient Advocate Groups. View 2022 Exhibitor List.
WORLDSymposium 2022 Poster Sessions
WORLDSymposium 2022 had 411 scientific abstracts presented at four (4) separate poster sessions. View 2022 Poster List.
WORLDSymposium 2022 Satellite Symposia
18 Satellite symposia were held from Monday, February 07, 2022 to Friday, February 11, 2022. Click here for the full schedule.
WORLDSymposium 2022 Young Investigator Awards
WORLDSymposium was pleased to announce the recipients of the 2022 Young Investigator Awards on Tuesday, February 8, 2022. More details.
WORLDSymposium 2022 Patient Advocate Leader (PAL) Award
WORLDSymposium 2022 Patient Advocate Leader (PAL) Award was received by Sue Kahn on Tuesday, February 8, 2022. For 14 years, Sue has served as the Executive Director of the National Tay-Sachs & Allied Diseases Association (NTSAD) that supports families affected by Tay-Sachs, Canavan, GM1, and Sandhoff. More details.
WORLDSymposium 2022 Keynote Speaker
Dr. Tippi MacKenzie’s Keynote Address: Prenatal enzyme replacement therapy for lysosomal disorders: Launching a phase I clinical trial, was on Wednesday, February 9, 2022, at 7:30 AM PST. Read speaker bio.
WORLDSymposium 2022 New Treatment Award
The WORLDSymposium 2022 New Treatment Awards were presented to Sanofi Genzyme and to JCR Pharmaceuticals on Thursday, February 10, 2022. More details.
WORLDSymposium 2022 Roscoe O. Brady Award
WORLDSymposium 2022 Roscoe O. Brady Award was presented to Stuart A. Kornfeld, MD on Monday, February 7, at 7:30 AM PST, followed by a scientific presentation from Dr. Kornfeld: Dissecting the Mannose 6-Phosphate Pathway – A Key to Understanding Lysosomal Enzyme Trafficking. View details.